Beam Therapeutics Inc. (BEAM) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$25.84
Day's range
$27.92

Beam Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ARK INVESTMENT MANAGEMENT LLC 02/11/2026 12.47 M $345.59 M   12.94% 12.15%
FMR LLC 02/17/2026 11.91 M $330.12 M   1.85% 11.61%
FARALLON CAPITAL MANAGEMENT LLC 02/17/2026 10.06 M $278.95 M   0.00% 9.81%
VANGUARD GROUP INC 01/29/2026 9.19 M $254.84 M   -0.62% 8.96%
BLACKROCK, INC. 02/12/2026 8.45 M $234.24 M   3.71% 8.24%
STATE STREET CORP 02/13/2026 5.23 M $144.93 M   30.43% 5.10%
ARCH VENTURE MANAGEMENT, LLC 02/17/2026 4.54 M $125.85 M   0.00% 4.43%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 01/23/2026 4.41 M $122.23 M   -8.72% 4.30%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 02/11/2026 4.41 M $122.18 M   -8.72% 4.30%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 2.73 M $75.68 M   20.64% 2.66%
KYNAM CAPITAL MANAGEMENT, LP 02/17/2026 2.44 M $67.64 M   -3.08% 2.38%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.35 M $65.21 M   -1.63% 2.29%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 1.95 M $54.00 M   13.23% 1.90%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 1.71 M $47.47 M   2.82% 1.67%
CASDIN CAPITAL, LLC 02/17/2026 1.60 M $44.35 M   0.00% 1.56%
REDMILE GROUP, LLC 02/17/2026 1.29 M $35.64 M   -7.33% 1.25%
02/17/2026 1.27 M $35.12 M   100.00% 1.24%
TWO SIGMA INVESTMENTS, LP 02/17/2026 1.12 M $31.06 M   195.58% 1.09%
WOODLINE PARTNERS LP 02/17/2026 993.07 K $27.53 M   81.69% 0.97%
UBS GROUP AG 01/29/2026 973.84 K $26.99 M   -14.40% 0.95%
MARSHALL WACE, LLP 02/13/2026 945.83 K $26.22 M   100.00% 0.92%
KYNAM CAPITAL MANAGEMENT, LP 02/17/2026 937.00 K $25.97 M   100.00% 0.91%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 834.80 K $23.14 M   -0.76% 0.81%
NORTHERN TRUST CORP 02/17/2026 808.95 K $22.42 M   -5.31% 0.79%
MORGAN STANLEY 02/13/2026 729.40 K $20.22 M   13.13% 0.71%
JPMORGAN CHASE & CO 02/11/2026 619.24 K $17.17 M   14.40% 0.60%
RTW INVESTMENTS, LP 02/17/2026 570.39 K $15.81 M   100.00% 0.56%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 02/17/2026 550.00 K $15.25 M   37.50% 0.54%
IQ EQ FUND MANAGEMENT (IRELAND) LTD 02/12/2026 533.56 K $14.79 M   39.12% 0.52%
CAPTION MANAGEMENT, LLC 02/17/2026 532.50 K $14.76 M   475.68% 0.52%
TWO SIGMA ADVISERS, LP 02/17/2026 527.80 K $14.63 M   58.50% 0.51%
GOLDMAN SACHS GROUP INC 03/25/2026 522.64 K $14.49 M   -60.37% 0.51%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 500.20 K $13.87 M   66.84% 0.49%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/17/2026 492.43 K $13.65 M   -60.92% 0.48%
02/17/2026 476.34 K $13.20 M   100.00% 0.46%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 468.91 K $13.00 M   1,856.24% 0.46%
BANK OF AMERICA CORP /DE/ 02/17/2026 427.33 K $11.85 M   -45.15% 0.42%
BAILLIE GIFFORD & CO 01/23/2026 416.22 K $11.54 M   39.76% 0.41%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 399.66 K $11.08 M   467.45% 0.39%
BANK OF NEW YORK MELLON CORP 02/10/2026 357.67 K $9.91 M   -12.64% 0.35%
BARCLAYS PLC 02/13/2026 326.18 K $9.04 M   4.00% 0.32%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 325.65 K $9.06 M   -3.51% 0.32%
ALPHABET INC. 02/13/2026 321.60 K $8.91 M   0.00% 0.31%
MILLENNIUM MANAGEMENT LLC 02/17/2026 301.65 K $8.36 M   913.95% 0.29%
PEREGRINE INVESTMENT MANAGEMENT INC 02/04/2026 257.28 K $7.13 M   -3.97% 0.25%
CITADEL ADVISORS LLC 02/17/2026 255.71 K $7.09 M   100.00% 0.25%
NUVEEN, LLC 02/12/2026 233.07 K $6.46 M   -1.80% 0.23%
CITADEL ADVISORS LLC 02/17/2026 218.90 K $6.07 M   -16.42% 0.21%
INVESCO LTD. 02/19/2026 213.19 K $5.91 M   20.54% 0.21%
VESTMARK ADVISORY SOLUTIONS, INC. 02/06/2026 196.04 K $5.43 M   17.88% 0.19%

Beam Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 335 institutional investors and hedge funds held shares of Beam Therapeutics Inc. The most heavily invested institutionals were:

ARK Investment Management LLC: 12.13 M

Nikko Asset Management Americas, Inc.: 3.83 M

Sumitomo Mitsui Trust Holdings, Inc.: 3.83 M

DIMENSIONAL FUND ADVISORS LP: 2.15 M

UBS Group AG: 826,061

BNP PARIBAS ARBITRAGE, SNC: 700,647

104.18% of Beam Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 129.60 M shares in the last 24 months. This purchase volume represents approximately $3.58 B in transactions.